Role of ultrasound-guided axillary fine-needle aspiration in the management of invasive breast cancer

American Journal of Surgery

Volumn 192, Issue 4, 2006, Pages 458-461

  Somasundar, Ponnandai ^a   Gass, Jennifer ^b   Steinhoff, Margaret ^b   Koeliker, Susan ^b   Dizon, Don ^b   Cady, Blake ^c   Taneja, Charu ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Axillary ultrasound; Breast cancer surgery; FNA

Indexed keywords

ADJUVANT CHEMOTHERAPY; ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURGERY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AXILLA; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; ULTRASONOGRAPHY, MAMMARY;

EID: 33748549998     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.06.029     Document Type: Article

References (26)

1. Pisani P., Parkin D.M., Bray F., et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83 (1999) 18-29
2. Donegan W.L. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47 (1997) 28-51
3. Joensuu H., Toikkanen S., and Klemi P.J. DNA index and S-phase fraction and their combinations as prognostic factors in operable ductal breast carcinoma. Cancer 66 (1990) 331-340
4. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 (2005) 4312-4321
5. Naik A., Fey J., Gemignanai M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow up study of 4008 procedures. Ann Surg 240 (2004) 462-471
6. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
7. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy of local regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 (1997) 2483-2493
8. Bonadonna G., Veronesi U., Brambilla C., et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82 (1990) 1539-1545
9. Oruwari J.U., Chung M.A., Koelliker S., et al. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. Am J Surg 184 (2002) 307-309
10. Fisher B., and Mamounas E.P. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 13 (1995) 537-540
11. Delena M., Zucali R., Viganotti G., et al. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1 (1978) 53-59
12. Lippman M.E., Srace R.A., Bagley C.S., et al. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. Natl Cancer Inst Monogr 1 (1986) 156-159
13. Mamounas E.P. Overview of national surgical adjuvant breast project-neoadjuvant chemotherapy studies. Semin Oncol 25 (1998) 31-35
14. Giuliano A.E., Kergan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-401
15. Veronesi V., Paganelli G., Galimberti V., et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349 (1997) 1864-1867
16. Lam W.W., Yang W.T., Chan Y.L., et al. Detection of axillary lymph node metastases in breast carcinoma by technetium 99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 23 (1996) 498-503
17. Herrada J., Iyer R.B., Atkinson E.N., et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 3 (1997) 1565-1569
18. Vlastos G., Fornage B.D., Mirza N.Q., et al. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg 179 (2000) 446-452
19. Kane III J.M., Edge S.B., Winston J.S., et al. Intraoperative pathologic evaluation of breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 8 (2001) 361-367
20. Zurrida S., Mazzarol G., Galimberti V., et al. The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol 8 (2001) 817-820
21. Motomura K., Inaji H., Komoike Y., et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 87 (2000) 597-601
22. Chao C., Wong S.L., Ackermann D., et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 182 (2001) 609-615
23. Dixon J.M., Mamman U., Thomas J., and Edinburgh Breast Unit team. Accuracy of intraoperative frozen-section analysis of axillary nodes. Br J Surg 86 (1999) 392-395
24. Henry-Tillman R.S., Korourian S., Rubio I.T., et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 9 (2002) 333-339
25. Kuerer H.M., Sahin A.A., Hunt K.K., et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230 (1999) 72-78
26. Newman L.A., Buzdar A.U., Singeletary S.E., et al. A prospective trial of preoperative chemotherapy in respectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 9 (2002) 228-234